You are here: Home Clinical Services Clinical Pathology George Rodgers, M.D.
Document Actions

George Rodgers, M.D.

last modified 2013-01-09 11:13 — by Jenny Johnson

Professor of Medicine

Professor of Pathology (Adjunct)

Scholarly Emphasis: Dr. Rodgers’ basic research is focused on endothelial cell biology as related to regulation of tissue factor and ADAMTS-13 activities. His clinic research deals with new treatments for bleeding and thrombotic disorders.
George Rodgers, M.D.

George M. Rodgers, M.D., Ph.D.

Contact Info

Email Address: George.Rodgers {{@}} hsc.utah.edu

Office Phone Number: (801) 585-3229

Location: 5C132 School of Medicine

Also Works in: ARUP Institute for Clinical and Experimental Pathology  

Division: Clinical Pathology

Also Works in: ARUP  

 

Titles:

  • • Medical Director, Hemostasis/Thrombosis Laboratory, ARUP Laboratories
  • • Adult Director, Mountain States Regional Hemophilia Center, University of Utah

About George Rodgers, M.D.


Dr. Rodgers came to the University of Utah in 1988 from the University of California San Francisco as an Associate Professor with a research interest in endothelial cell regulation of blood coagulation. Dr. Rodgers was one of the first investigators to define the roles of vascular cells in hemostasis, including prothrombin activation, tissue factor activity, factor V activity, and atherogenic stimuli. In the 1990s, he expanded his investigative interests into clinical laboratory coagulation and thrombosis. He has actively participated in clinical trials of new therapies for venous thromboembolism, and has been the coagulation editor for Wintrobe’s Clinical Hematology since 1998. He has authored other coagulation texts, including Case Studies in Hemostasis: Laboratory Diagnosis and Management and Laboratory Hemostasis: A Practical Guide for Pathologists. He is currently chair of the National Comprehensive Cancer Network Panel on Anemia. Dr. Rodgers is the primary clinical consultant for patients in the intermountain area with disorders of hemostasis and has consulted nationally through ARUP Laboratories on the subject of clinical laboratory coagulation. He has given lectures and research presentations at regional, national, and international meetings.

Selected Publications

  • • Rodgers, George M., Greenberg, Charles S., and Shuman, Marc A.: Characterization of the Effects of Cultured Vascular Cells on the Activation of Blood Coagulation. Blood 61:1155 1162, 1983.
  • • Rodgers, George M. and Shuman, Marc A.: Prothrombin is Activated on Vascular Endothelial Cells by Factor Xa and Calcium. Proc. Natl. Acad. Sci. USA. 80:7001 7005, 1983.
  • • Bloom, Elana J., Abrams, Donald I., and Rodgers, George M.: Lupus Anti-coagulant in the Acquired Immunodeficiency Syndrome. J. Amer. Med. Assoc. 256:491 493, 1986.
  • • Rodgers, George M.: Hemostatic Properties of Normal and Perturbed Vascular Cells. FASEB Journal. 2:116 123, 1988.
  • • Rodgers, George M. and Conn, Marion T.: Homocysteine, an Atherogenic Stimulus, Reduces Protein C Activation by Arterial and Venous Endothelial Cells. Blood 75:895-901, 1990.
  • • Fryer, Richard H., Wilson, Brent D., Gubler, D. B., Fitzgerald, Laurence A., and Rodgers, George M.: Homocysteine, A Risk Factor For Premature Vascular Disease and Thrombosis, Induces Tissue Factor Activity in Endothelial Cells. Arteriosclerosis and Thrombosis 13:1327-1333, 1993.
  • • Liu, Lihua and Rodgers, George M.: Characterization of an Inducible Endothelial Cell Prothrombin Activator. Blood 88:2989-2994, 1996.
  • • Rodgers, George M.: CASE STUDIES IN HEMOSTASIS: LABORATORY DIAGNOSIS AND MANAGEMENT. ASCP Press, Chicago, 2000.
  • • The Enoxaparin Clinical Trial Group: Writing Committee Members: Merli, Geno, Spiro, Theodore E., Olsson, Carl G., Abildgaard, U., Davidson, Bruce L., Eldor, Amiram, Elias, Darlene, Grigg, Andrew, Musset, Dominique, Rodgers, George M., Trowbridge, Arthur A., Yusen, Roger D., and Zawilska, Krystyna: Subcutaneous Enoxaparin Once or Twice Daily Compared with Intravenous Unfractionated Heparin for Treatment of Venous Thromboembolic Disease. Ann Intern Med 134:191-202, 2001.
  • • Lehman, Christopher M., Blaylock, Robert C., Alexander, Donald P., and Rodgers, George M.: Discontinuation of the Bleeding Time Test Without Detectable Adverse Clinical Impact. Clin Chem 47:1204-1211, 2001.
  • • Lehman, Chris M., Wilson, Lori W., and Rodgers, George M.: Analytical Validation and Clinical Evaluation of the Utility of the STA LIATEST D-Dimer Assay for the Diagnosis of Disseminated Intravascular Coagulation. Am J Clin Path. 122:178-184, 2004.
  • • Terry, Christi M., Kling, Stephen J., Cheang Kai I., Hoidal, John R., and Rodgers, George M.: Polymorphisms in the 5’-Untranslated Region of the Tissue Factor Gene are Associated with Altered Expression in Human Endothelial Cells. J Thromb Haemost. 2:1351-1358, 2004.
  • • Stinnett, Jason M., Pendleton, Robert C., Skordos, Le Ann, Wheeler, Michelle M., and Rodgers, George M.: Venous Thromboembolism Prophylaxis in Medically-Ill Patients and the Development of Strategies to Improve Prophylaxis Rates. Am J Hematol. 78:167-172, 2005.
  • • Flanders, Michele M., Crist, Ronda, Roberts, William, and Rodgers, George M.: Pediatric Reference Intervals for Seven Common Coagulation Assays. Clin Chem 51:1738-1742, 2005.
  • • Rodgers, George M.: Bleeding Disorders, Thrombotic Disorders, and Anticoagulant Therapy. Chapters 26-34. In PRACTICAL DIAGNOSIS OF HEMATOLOGIC DISORDERS (Kjeldsberg, C., Eds.) ASCP Press, Chicago, Fourth edition, 2006.
  • • Bennett, Sterling, Lehman, Christopher M., and Rodgers, George M. LABORATORY HEMOSTASIS: A PRACTICAL GUIDE FOR PATHOLOGISTS. Springer, New York, 2007.
  • All Publications: Click Here

Honors and Awards

  • • Dr. Frank N. Cochems Essay Prize in the field of vascular disease, 1982
  • • NIH (NHLBI) Clinical Investigator Award (HL01031), 1982 – 1987
  • • Irvine H. Page Arteriosclerosis Research Award for Young Investigators – Second Place, American Heart Association, 1987
  • • Resident Teaching Award, Department of Laboratory Medicine, UCSF, 1987 – 1988

Professional Education

  • • 1966 – 1970 – B.S. (Biochemistry), Louisiana State University, Baton Rouge, LA
  • • 1970 – 1976 – M.D., Ph.D. (Pharmacology), Tulane University, New Orleans, LA
  • • 1976 – 1979 – Internal Medicine Residency, Baylor College of Medicine, Houston, TX
  • • 1979 – 1982 – Fellow – Hematology, University of California San Francisco, San Francisco, CA